Health Care & Life Sciences » Biotechnology | ADMA Biologics Inc.

ADMA Biologics Inc.

ADMA Biologics Inc.
Stock Exchange NASDAQ Stock Market
EPS
$1.34
Market Cap
$212.95 M
Shares Outstanding
59.32 M
Public Float
29.53 M

Profile

Address
465 State Route 17 South
Ramsey New Jersey 07446
United States
Employees -
Website http://www.admabiologics.com
Updated 07/08/2019
ADMA Biologics, Inc. is a biopharmaceutical company. It develops, manufactures, and intends to commercialize in human plasma and plasma-derived therapeutics. It operates through the following business segments: ADMA BioManufacturing, Plasma Collection Center, and Corporate.

Financials

View All
Created with Highcharts 5.0.14ADMA Biologics Inc.Net Income. Fiscal year is January-December. All values USD Thousands.15 52715 52716 81316 81317 96917 96919 51519 51543 75943 75965 74365 743201320142015201620172018020k40k60k80k
Created with Highcharts 5.0.14ADMA Biologics Inc.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.3 0673 0675 9155 9157 1777 17710 66110 66122 76022 76016 98516 98520132014201520162017201805k10k15k20k25k

Steven Arnote Elms
Chairman
Adam S. Grossman
President, Chief Executive Officer & Director